Similar to CD4+FOXP3+ Treg, CD8+FOXP3+ T cells with apparent immunosuppressive capacity have been reported in human malignancies such as colorectal cancer and ovarian cancer (76). This evidence concerns the gene FOXP3 and ovarian carcinoma.